George Tidmarsh
From Wikipedia, the free encyclopedia
PresidentDonald Trump
Preceded byJacqueline Corrigan-Curay
Succeeded byRichard Pazdur
PresidentDonald Trump
George Tidmarsh | |
|---|---|
| Director of U.S. Center for Drug Evaluation and Research | |
| In office July 21, 2025 – November 2, 2025 | |
| President | Donald Trump |
| Preceded by | Jacqueline Corrigan-Curay |
| Succeeded by | Richard Pazdur |
| temporary Director of U.S. Center for Biologics Evaluation and Research | |
| In office July 31, 2025 – August 9, 2025 | |
| President | Donald Trump |
| Preceded by | Vinay Prasad |
| Succeeded by | Vinay Prasad |
| Personal details | |
| Born | 1960 (age 65–66) Oak Park, Illinois, U.S. |
| Alma mater | Stanford University |
George Tidmarsh (born 1960) is an American politician and businessman who served as the Director of U.S. Center for Drug Evaluation and Research from July to October 2025.[1][2] He was also the temporary Director of U.S. Center for Biologics Evaluation and Research after Vinay Prasad resigned,[3] until Prasad returned 10 days later.[4]
Tidmarsh attended Stanford University for his undergraduate degree and subsequently MD and PhD in Cancer Biology.[1][5]
